We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

YXT:NASDAQYXT.COM GROUP HOLDING LIMITED - American Depository Shares Analysis

Data as of 2026-06-21 - not real-time

$0.39

Latest Price

8/10Risk

Risk Level: High

Executive Summary

YXT is trading at $0.391, well below its 20‑day (0.445), 50‑day (0.484) and 200‑day (0.711) simple moving averages, indicating a sustained downtrend. The MACD is bearish (line –0.025 vs signal –0.019) and the RSI sits at 43, suggesting limited upside momentum. Price is hovering just above the identified support of $0.325 and far from the resistance at $0.75, while the 30‑day volatility spikes at 167% and beta is –0.76, underscoring extreme price swings and an inverse market correlation. Fundamentally, the company posts modest revenue growth (4.7%) and a strong gross margin (68%) but suffers deep operating losses (‑40% margin) and negative cash flows, with a debt‑to‑equity ratio of ~250, indicating a precarious balance sheet. The price‑to‑sales ratio of 0.07 is cheap, yet the lack of earnings (PE –24) and zero dividend yield make the valuation fragile.
Given the increasing but still very low trading volume, high liquidity risk, and a “Extreme Greed” market sentiment (fear‑greed index 91.46), the stock appears vulnerable to further declines. Investors should weigh the cheap relative valuation against the substantial operational and financial headwinds before taking a position.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Price below all major SMAs and bearish MACD
  • Proximity to support with high volatility
  • Weak liquidity and thin trading volume

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Cheap price‑to‑sales ratio offering some value upside
  • Continued operating losses and high debt load
  • Uncertain regulatory environment for Chinese ed‑tech

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Potential for revenue growth if margins improve
  • Persistent balance‑sheet weakness and cash‑flow deficits
  • Exposure to Chinese market and policy risk

Key Metrics & Analysis

Financial Health

Revenue Growth4.70%
Profit Margin-46.71%
P/E Ratio-24.1
ROE-105.30%
ROA-13.26%
Debt/Equity249.78
P/B Ratio2.2
Op. Cash Flow$-145866000
Free Cash Flow$-83922376
Industry P/E38.1

Technical Analysis

TrendBearish
RSI43.5
Support$0.32
Resistance$0.75
MA 20$0.44
MA 50$0.48
MA 200$0.71
MACDBearish
VolumeIncreasing
Fear & Greed Index91.46

Valuation

GradeFair
TypeValue

Risk Assessment

Beta-0.76
Volatility167.71%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.